Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001677036-26-000009

Options or other derivatives

  • Director acquired 1,352 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lind Kevin Robert · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-30 Grant or award : show line 1 in the form Stock Option (Right to Buy) +1,352 $12.29 $16,616 1,352 D
Loading xslF345X06/form4-10022026_041018.xml…